Nikko Asset Management Americas Inc. 13D and 13G filings for Pacific Biosciences of California, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-12 5:12 pm Sale | 2023-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | Nikko Asset Management Americas Inc. | 13,200,375 4.930% | -965,818 (-6.82%) | Filing |
| 2023-02-10 10:29 am Purchase | 2022-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | Nikko Asset Management Americas Inc. | 14,166,193 6.260% | 2,251,168 (+18.89%) | Filing |
| 2022-02-14 06:05 am Purchase | 2021-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | Nikko Asset Management Americas Inc. | 11,915,025 5.400% | 11,915,025 (New Position) | Filing |